We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Seattle Genetics Reports Durable Objective Responses with SGN-35 in Lymphoma

News   Dec 08, 2008

 
Seattle Genetics Reports Durable Objective Responses with SGN-35 in Lymphoma
 
 
 

RELATED ARTICLES

Progress in Cochlear Regeneration

News

This research demonstrates a signaling pathway that can be activated by different methods and could represent a new approach to cochlear regeneration and, ultimately, restoration of hearing.

READ MORE

Drug Cocktail Could Increase Lifespan

News

A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.

READ MORE

Aspirin Stops Clots After Knee Surgery

News

Putting patients on aspirin following a knee replacement is a safe, cost-effective alternative to anticoagulants, U-M researchers find.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE